253 related articles for article (PubMed ID: 16630319)
1. Kawasaki disease in New Zealand.
Heaton P; Wilson N; Nicholson R; Doran J; Parsons A; Aiken G
J Paediatr Child Health; 2006 Apr; 42(4):184-90. PubMed ID: 16630319
[TBL] [Abstract][Full Text] [Related]
2. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
Wilson N; Heaton P; Calder L; Nicholson R; Stables S; Gavin R
J Paediatr Child Health; 2004; 40(9-10):524-9. PubMed ID: 15367145
[TBL] [Abstract][Full Text] [Related]
3. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Tse SM; Silverman ED; McCrindle BW; Yeung RS
J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
[TBL] [Abstract][Full Text] [Related]
4. Five years of Kawasaki disease in the Netherlands: a national surveillance study.
Tacke CE; Breunis WB; Pereira RR; Breur JM; Kuipers IM; Kuijpers TW
Pediatr Infect Dis J; 2014 Aug; 33(8):793-7. PubMed ID: 24463809
[TBL] [Abstract][Full Text] [Related]
5. Epidemiologic study of Kawasaki disease at a single hospital in Daejeon, Korea (1987 through 2000).
Lee KY; Han JW; Lee HS; Hong JH; Hahn SH; Lee JS; Whang KT
Pediatr Infect Dis J; 2004 Jan; 23(1):52-5. PubMed ID: 14743047
[TBL] [Abstract][Full Text] [Related]
6. Preventing coronary artery abnormalities: a need for earlier diagnosis and treatment of Kawasaki disease.
Dominguez SR; Anderson MS; El-Adawy M; Glodé MP
Pediatr Infect Dis J; 2012 Dec; 31(12):1217-20. PubMed ID: 22760536
[TBL] [Abstract][Full Text] [Related]
7. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark.
Patel A; Holman RC; Callinan LS; Sreenivasan N; Schonberger LB; Fischer TK; Belay ED
Acta Paediatr; 2013 Apr; 102(4):385-90. PubMed ID: 23278838
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology and clinical features of Kawasaki disease in Australia.
Saundankar J; Yim D; Itotoh B; Payne R; Maslin K; Jape G; Ramsay J; Kothari D; Cheng A; Burgner D
Pediatrics; 2014 Apr; 133(4):e1009-14. PubMed ID: 24685950
[TBL] [Abstract][Full Text] [Related]
10. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011.
Kim GB; Han JW; Park YW; Song MS; Hong YM; Cha SH; Kim DS; Park S
Pediatr Infect Dis J; 2014 Jan; 33(1):24-7. PubMed ID: 24064559
[TBL] [Abstract][Full Text] [Related]
11. Infections and Kawasaki disease: implications for coronary artery outcome.
Benseler SM; McCrindle BW; Silverman ED; Tyrrell PN; Wong J; Yeung RS
Pediatrics; 2005 Dec; 116(6):e760-6. PubMed ID: 16322132
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome.
Baer AZ; Rubin LG; Shapiro CA; Sood SK; Rajan S; Shapir Y; Romano A; Bierman FZ
Arch Pediatr Adolesc Med; 2006 Jul; 160(7):686-90. PubMed ID: 16818833
[TBL] [Abstract][Full Text] [Related]
13. Clinical and epidemiological characteristics of children with Kawasaki disease in Turkey.
Ozdemir H; Ciftçi E; Tapisiz A; Ince E; Tutar E; Atalay S; Dogru U
J Trop Pediatr; 2010 Aug; 56(4):260-2. PubMed ID: 20007257
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012.
Chen JJ; Ma XJ; Liu F; Yan WL; Huang MR; Huang M; Huang GY;
Pediatr Infect Dis J; 2016 Jan; 35(1):7-12. PubMed ID: 26372452
[TBL] [Abstract][Full Text] [Related]
15. Rising Kawasaki disease incidence in New Zealand: analysis of national population incidence and outcomes 2000-2017.
Gee P; Burgner D; Gee W; Forbes A; Frampton CMA; McCombie A
Arch Dis Child; 2023 Nov; 108(11):916-921. PubMed ID: 37553209
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
Khowsathit P; Hong-Hgam C; Khositseth A; Wanitkun S
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002.
Chang LY; Chang IS; Lu CY; Chiang BL; Lee CY; Chen PJ; Wang JT; Ho HN; Chen DS; Huang LM;
Pediatrics; 2004 Dec; 114(6):e678-82. PubMed ID: 15574600
[TBL] [Abstract][Full Text] [Related]
18. Kawasaki disease in Auckland, 1979-1988.
Gentles TL; Clarkson PM; Trenholme AA; Lennon DR; Neutze JM
N Z Med J; 1990 Aug; 103(896):389-91. PubMed ID: 2385416
[TBL] [Abstract][Full Text] [Related]
19. The Clinical Profile of Kawasaki Disease in Algerian Children: A Single Institution Experience.
Boudiaf H; Achir M
J Trop Pediatr; 2016 Apr; 62(2):139-43. PubMed ID: 26655639
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: a review of three years experience.
Singh-Grewal D; Wong M; Isaacs D
J Paediatr Child Health; 2005; 41(9-10):495-9. PubMed ID: 16150066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
